CannLabs, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CANL research report →
Companywww.cannlabs.net
CannLabs, Inc. provides cannabis testing laboratory services in the United States. Its testing services include potency testing, residual solvent analysis, microbiological testing, pesticide testing, heavy metals testing, nutrient analysis, terpenes analysis, shelf-life/stability studies, gene expression testing, and genotyping/phenotyping testing.
- CEO
- Mark C. Mirken
- IPO
- 2014
- Employees
- 37
- HQ
- Denver, CO, US
Price Chart
Valuation
- Market Cap
- $93.32K
- P/E
- 0.09
- P/S
- 0.02
- P/B
- 0.03
- EV/EBITDA
- -0.63
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 46.97%
- Op Margin
- 19.86%
- Net Margin
- 19.79%
- ROE
- 37.82%
- ROIC
- 27.67%
Growth & Income
- Revenue
- $4.39M · 38.04%
- Net Income
- $869.17K · 21.94%
- EPS
- $0.00 · 22.22%
- Op Income
- $872.24K
- FCF YoY
- 44.85%
Performance & Tape
- 52W High
- $0.01
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 5.59
- Avg Volume
- 981
Get TickerSpark's AI analysis on CANL
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our CANL Coverage
We haven't published any research on CANL yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate CANL Report →